Literature DB >> 23139382

Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?

Jerome Wielens1, Stephen J Headey, David I Rhodes, Roger J Mulder, Olan Dolezal, John J Deadman, Janet Newman, David K Chalmers, Michael W Parker, Thomas S Peat, Martin J Scanlon.   

Abstract

Fragment screening is becoming widely accepted as a technique to identify hit compounds for the development of novel lead compounds. In neighboring laboratories, we have recently, and independently, performed a fragment screening campaign on the HIV-1 integrase core domain (IN) using similar commercially purchased fragment libraries. The two campaigns used different screening methods for the preliminary identification of fragment hits; one used saturation transfer difference nuclear magnetic resonance spectroscopy (STD-NMR), and the other used surface plasmon resonance (SPR) spectroscopy. Both initial screens were followed by X-ray crystallography. Using the STD-NMR/X-ray approach, 15 IN/fragment complexes were identified, whereas the SPR/X-ray approach found 6 complexes. In this article, we compare the approaches that were taken by each group and the results obtained, and we look at what factors could potentially influence the final results. We find that despite using different approaches with little overlap of initial hits, both approaches identified binding sites on IN that provided a basis for fragment-based lead discovery and further lead development. Comparison of hits identified in the two studies highlights a key role for both the conditions under which fragment binding is measured and the criteria selected to classify hits.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23139382     DOI: 10.1177/1087057112465979

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  19 in total

1.  Identification of mechanistically distinct inhibitors of HIV-1 reverse transcriptase through fragment screening.

Authors:  Jennifer La; Catherine F Latham; Ricky N Tinetti; Adam Johnson; David Tyssen; Kelly D Huber; Nicolas Sluis-Cremer; Jamie S Simpson; Stephen J Headey; David K Chalmers; Gilda Tachedjian
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-18       Impact factor: 11.205

Review 2.  Twenty years on: the impact of fragments on drug discovery.

Authors:  Daniel A Erlanson; Stephen W Fesik; Roderick E Hubbard; Wolfgang Jahnke; Harren Jhoti
Journal:  Nat Rev Drug Discov       Date:  2016-07-15       Impact factor: 84.694

3.  Virtual screening with AutoDock Vina and the common pharmacophore engine of a low diversity library of fragments and hits against the three allosteric sites of HIV integrase: participation in the SAMPL4 protein-ligand binding challenge.

Authors:  Alexander L Perryman; Daniel N Santiago; Stefano Forli; Diogo Santos Martins; Arthur J Olson
Journal:  J Comput Aided Mol Des       Date:  2014-02-04       Impact factor: 3.686

4.  Interrogating HIV integrase for compounds that bind--a SAMPL challenge.

Authors:  Thomas S Peat; Olan Dolezal; Janet Newman; David Mobley; John J Deadman
Journal:  J Comput Aided Mol Des       Date:  2014-02-16       Impact factor: 3.686

5.  Identification and optimization of PDE10A inhibitors using fragment-based screening by nanocalorimetry and X-ray crystallography.

Authors:  Michael I Recht; Vandana Sridhar; John Badger; Pierre-Yves Bounaud; Cheyenne Logan; Barbara Chie-Leon; Vicki Nienaber; Francisco E Torres
Journal:  J Biomol Screen       Date:  2013-12-27

6.  Inspecting the Mechanism of Fragment Hits Binding on SARS-CoV-2 Mpro by Using Supervised Molecular Dynamics (SuMD) Simulations.

Authors:  Maicol Bissaro; Giovanni Bolcato; Matteo Pavan; Davide Bassani; Mattia Sturlese; Stefano Moro
Journal:  ChemMedChem       Date:  2021-05-06       Impact factor: 3.540

7.  Basic quinolinonyl diketo acid derivatives as inhibitors of HIV integrase and their activity against RNase H function of reverse transcriptase.

Authors:  Roberta Costi; Mathieu Métifiot; Suhman Chung; Giuliana Cuzzucoli Crucitti; Kasthuraiah Maddali; Luca Pescatori; Antonella Messore; Valentina Noemi Madia; Giovanni Pupo; Luigi Scipione; Silvano Tortorella; Francesco Saverio Di Leva; Sandro Cosconati; Luciana Marinelli; Ettore Novellino; Stuart F J Le Grice; Angela Corona; Yves Pommier; Christophe Marchand; Roberto Di Santo
Journal:  J Med Chem       Date:  2014-04-11       Impact factor: 7.446

8.  Fragment-based screening maps inhibitor interactions in the ATP-binding site of checkpoint kinase 2.

Authors:  M Cris Silva-Santisteban; Isaac M Westwood; Kathy Boxall; Nathan Brown; Sam Peacock; Craig McAndrew; Elaine Barrie; Meirion Richards; Amin Mirza; Antony W Oliver; Rosemary Burke; Swen Hoelder; Keith Jones; G Wynne Aherne; Julian Blagg; Ian Collins; Michelle D Garrett; Rob L M van Montfort
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

9.  Computational and experimental prediction of human C-type lectin receptor druggability.

Authors:  Jonas Aretz; Eike-Christian Wamhoff; Jonas Hanske; Dario Heymann; Christoph Rademacher
Journal:  Front Immunol       Date:  2014-07-10       Impact factor: 7.561

Review 10.  Charting a Path to Success in Virtual Screening.

Authors:  Stefano Forli
Journal:  Molecules       Date:  2015-10-15       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.